Singapore markets closed
Straits Times Index
3,230.55 +21.37 (+0.67%) Nikkei
26,781.68 +176.84 (+0.66%) Hang Seng
20,697.36 +581.16 (+2.89%) FTSE 100
7,585.46 +20.54 (+0.27%) BTC-USD
28,998.62 +175.60 (+0.61%) CMC Crypto 200
625.79 -3.71 (-0.59%)
NeuBase Therapeutics, Inc. (NBSE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 32.58M |
| Enterprise value | -56.74k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.85 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.00 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.77 |
| 52-week change 3 | -80.27% |
| S&P500 52-week change 3 | -1.04% |
| 52-week high 3 | 5.5100 |
| 52-week low 3 | 0.8900 |
| 50-day moving average 3 | 1.4163 |
| 200-day moving average 3 | 2.4827 |
Share statistics
| Avg vol (3-month) 3 | 84.83k |
| Avg vol (10-day) 3 | 57.78k |
| Shares outstanding 5 | 32.26M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 28.04M |
| % held by insiders 1 | 8.69% |
| % held by institutions 1 | 37.61% |
| Shares short (12 May 2022) 4 | 410.08k |
| Short ratio (12 May 2022) 4 | 5.03 |
| Short % of float (12 May 2022) 4 | 1.29% |
| Short % of shares outstanding (12 May 2022) 4 | 1.27% |
| Shares short (prior month 13 Apr 2022) 4 | 463k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 03 Feb 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 03 Feb 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 29 Sept 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -54.47% |
| Return on equity (ttm) | -107.81% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -32.62M |
| Net income avi to common (ttm) | -33.47M |
| Diluted EPS (ttm) | -1.0440 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 38.96M |
| Total cash per share (mrq) | 1.21 |
| Total debt (mrq) | 6.32M |
| Total debt/equity (mrq) | 16.56 |
| Current ratio (mrq) | 8.07 |
| Book value per share (mrq) | 1.18 |
Cash flow statement
| Operating cash flow (ttm) | -25.03M |
| Levered free cash flow (ttm) | -17.54M |
© 2022 Yahoo. All rights reserved.
